{"id":744,"date":"2020-05-12T01:21:22","date_gmt":"2020-05-12T01:21:22","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=744"},"modified":"2023-08-29T18:02:05","modified_gmt":"2023-08-29T18:02:05","slug":"pharmaust-progress-towards-next-clinical-trial-monepantel","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=744","title":{"rendered":"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c"},"content":{"rendered":"<p>\u80bf\u7624\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=PAA&amp;lang=cn\">PharmAust (ASX: PAA)<\/a>\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002<\/p>\n<p>\u8be5\u8bd5\u9a8c\u76ee\u524d\u88ab\u6401\u7f6e\uff0c\u7b49\u5f85\u5f00\u53d1\u5408\u4f5c\u4f19\u4f34Elanco US\u7684\u4e2d\u671f\u62a5\u544a\uff0c\u6b64\u524d\u66fe\u6709\u72d7\u5728\u9ad8\u5242\u91cf\u6c34\u5e73\u4e0b\u51fa\u73b0\u809d\u9176\u5347\u9ad8\u548c\u98df\u6b32\u4e0d\u632f\u7684\u60c5\u51b5\u3002<\/p>\n<p>\u5728\u5411\u5e02\u573a\u53d1\u5e03\u7684\u4e00\u4efd\u58f0\u660e\u4e2d\uff0c\u8be5\u516c\u53f8\u8868\u793a\uff0c\u5176\u6700\u65b0\u7684\u8bd5\u9a8c\u63d0\u4f9b\u4e86\u4e00\u4e2a\u201c\u6709\u610f\u4e49\u7684\u8d8b\u52bf\u201d\uff0c\u4e0e2017\u5e74\u7684\u6db2\u6001\u7248monepantel\u8bd5\u9a8c\u76f8\u6bd4\uff0c\u6548\u679c\u8fd8\u4e0d\u9519\u3002<\/p>\n<p>\u6700\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u8be5\u516c\u53f8\u5ba3\u5e03\u8be5\u8bd5\u9a8c\u5df2\u7ecf\u8fbe\u5230\u4e86\u6240\u6709\u7684\u4e3b\u8981\u76ee\u6807\uff0c\u5305\u62ec\u786e\u5b9amonepantel\u7247\u5242\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u8bc4\u4f30\u65b0\u5f00\u53d1\u7684monepantel\u7247\u5242\u5728\u60a3\u6709\u764c\u75c7\u7684\u72d7\u8eab\u4e0a\u7684\u836f\u7269\u4f20\u9012\u80fd\u529b\uff0c\u4ea7\u751f\u8db3\u591f\u7684\u6570\u636e\u4ee5\u4fbf\u4e0eElanco US\u8fdb\u4e00\u6b65\u8ba8\u8bba\uff0c\u53ef\u80fd\u6700\u91cd\u8981\u7684\u662f\u8db3\u591f\u7684\u6570\u636e\u8fdb\u5165\u7b2c\u4e09\u9636\u6bb5\u7684\u8bd5\u9a8c<\/p>\n<p>\u603b\u5171\u67096\u53ea\u72d7\u63a5\u53d7\u4e86monepantel\u6cbb\u7597\uff0c\u8fd9\u662f\u5728\u5bb6\u91cc\u8fdb\u884c\u768428\u5929\u6cbb\u7597\u8ba1\u5212\u7684\u4e00\u90e8\u5206\u3002<\/p>\n<p>\u5728\u5b8c\u6210\u8bc4\u4f30\u7684\u72d7\u4e2d\uff0c\u4e00\u53ea\u72d7\u5b9e\u73b0\u4e86\u90e8\u5206\u53cd\u5e94\uff0c\u603b\u80bf\u7624\u8d1f\u62c5\u51cf\u5c11\u4e8660%\u4ee5\u4e0a\uff0c\u4e00\u4e2a\u6dcb\u5df4\u7ed3\u80bf\u7624\u5b8c\u5168\u6d88\u9000\u3002\u540c\u65f6\uff0c\u5728\u8bd5\u9a8c\u7ed3\u675f\u65f6\uff0c4\u53ea\u72d7\u75c5\u60c5\u7a33\u5b9a\uff0c1\u53ea\u72d7\u75c5\u60c5\u8fdb\u5c55\u3002<\/p>\n<p>\u9664\u4e86\u4eca\u5929\u516c\u5e03\u7684\u7ed3\u679c\uff0cPharmAust\u8bf4\uff0c\u4ece\u8bd5\u9a8c\u671f\u95f4\u8bb0\u5f55\u7684\u8840\u6d46monepantel\u6c34\u5e73\u6765\u770b\uff0c\u6240\u6709\u72d7\u7684\u8840\u6d46monepantel\u6c34\u5e73\u90fd\u6bd42014\/2015\u5e74\u5728\u963f\u5fb7\u83b1\u5fb7\u7687\u5bb6\u533b\u9662\u8fdb\u884c\u7684\u4eba\u4f53\u8bd5\u9a8c\u8bb0\u5f55\u7684\u6c34\u5e73\u9ad850\u500d\u3002<\/p>\n<p>\u201c\u5728\u8840\u6d46\u6c34\u5e73\u4e0a\u89c2\u5bdf\u5230\u4e00\u4e9b\u53d8\u5316\uff0c\u51fa\u4e4e\u610f\u6599\u7684\u662f\uff0c\u5728\u8f83\u4f4e\u7684\u8840\u6db2\u6c34\u5e73\u7684\u83ab\u5c3c\u73ed\u7279\u6709\u66f4\u597d\u7684\u7ed3\u679c\u3002\u201d\u8fd9\u4e00\u89c2\u5bdf\u7ed3\u679c\u53ef\u80fd\u4e0emTOR\u6291\u5236\u5242\u7684\u4f5c\u7528\u673a\u5236\u76f8\u4e00\u81f4\uff0c\u6709\u52a9\u4e8e\u51cf\u5c11\u548c\u4f18\u5316\u672a\u6765monepantel\u7247\u7684\u5242\u91cf\uff0c\u201d\u8be5\u516c\u53f8\u8bf4\u3002<\/p>\n<p>\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u8bd5\u9a8c\u7ed3\u679c\u663e\u793a\u4e0e\u5242\u91cf\u6709\u5173\u7684\u610f\u5916\u7ed3\u679c\u3002<\/p>\n<p>\u636ePharmAust\u8bf4\uff0c\u7531\u4e8e\u9ad8\u5242\u91cf\u7684\u4f7f\u7528\uff0c\u4e00\u4e9b\u5ba0\u7269\u72d7\u51fa\u73b0\u98df\u6b32\u4e0d\u632f\u548c\u4f53\u91cd\u4e0b\u964d\u3002<\/p>\n<p>\u56e0\u6b64\uff0c\u5ba0\u7269\u4e3b\u4eba\u62a5\u544a\u8bf4\u7ed9\u5ba0\u7269\u670d\u7528\u7247\u5242\u6709\u56f0\u96be\uff0c\u8fd9\u610f\u5473\u7740\u5728\u672a\u6765\u7684\u8bd5\u9a8c\u4e2d\u51cf\u5c11\u76ee\u6807\u5242\u91cf\u53ef\u80fd\u4f1a\u5728\u7597\u6548\u3001\u5b89\u5168\u6027\u548c\u7ed9\u5ba0\u7269\u7528\u836f\u65b9\u9762\u4ea7\u751f\u66f4\u597d\u7684\u7ed3\u679c\u3002<\/p>\n<h2>\u62bc\u6ce8monepantel<\/h2>\n<p>PharmAust\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269monepantel\u662fmTOR\u9014\u5f84\u7684\u6291\u5236\u5242\uff0cmTOR\u9014\u5f84\u88ab\u8ba4\u4e3a\u662f\u764c\u75c7\u7684\u5173\u952e\u9a71\u52a8\u56e0\u7d20\u3002<\/p>\n<p>Monepantel\u5df2\u7ecf\u5728\u4eba\u7c7b\u548c\u72d7\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u8fdb\u884c\u4e86\u8bc4\u4f30\uff0c\u8010\u53d7\u6027\u826f\u597d\uff0c\u5e76\u4ea7\u751f\u4e86\u5173\u952e\u9884\u540e\u751f\u7269\u6807\u5fd7\u7269\u7684\u663e\u8457\u964d\u4f4e\u3002<\/p>\n<p>\u6765\u81ea\u58a8\u5c14\u672c\u5927\u5b66\u548cU-Vet Werribee\u52a8\u7269\u533b\u9662\u7684Claire Cannon\u535a\u58eb\u8bf4:\u201cmonepantel\u4f3c\u4e4e\u5728\u60a3\u6709\u6dcb\u5df4\u7624\u7684\u72d7\u8eab\u4e0a\u663e\u793a\u51fa\u4e86\u6297\u764c\u6d3b\u6027\uff0c\u6211\u8ba4\u4e3a\uff0c\u73b0\u5728\u6709\u5fc5\u8981\u5bf9\u4f4e\u5242\u91cfmonepantel\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u8fdb\u884c\u4e09\u671f\u5bf9\u7167\u8bd5\u9a8c\u3002\u201d<\/p>\n<p>\u5979\u8bf4:\u201c\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c\u7684\u7ed3\u679c\u8868\u660e\uff0cmonepantel\u53ef\u80fd\u4e0e\u6807\u51c6\u62a4\u7406\u6dcb\u5df4\u7624\u6cbb\u7597\u76f8\u7ed3\u5408\uff0c\u53ef\u80fd\u4ee3\u8868\u4e86\u6cbb\u7597\u8fd9\u79cd\u75be\u75c5\u7684\u72d7\u7684\u672a\u6765\u524d\u666f\u3002\u201d<\/p>\n<p>\u6839\u636ePharmAust\u7684\u8bf4\u6cd5\uff0c\u5b83\u73b0\u5728\u5904\u4e8e\u201c\u72ec\u7279\u7684\u5730\u4f4d\u201d\uff0c\u5728\u63a8\u8fdb\u836f\u7269\u7684\u7b2c\u4e8c\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u540c\u65f6\uff0c\u5c06monepantel\u7528\u4e8e\u6cbb\u7597\u4eba\u7c7b\u548c\u517d\u533b\u764c\u75c7\u7684\u5546\u4e1a\u5316\u3002<\/p>\n<p>\u201c\u5728\u4e00\u53ea\u72d7\u8eab\u4e0a\uff0c\u670d\u7528monepantel\u7247\u53ef\u4ee5\u51cf\u5c1160%\u7684\u80bf\u7624\u8d1f\u62c5\uff0c\u8ba9\u4e00\u4e2a\u6dcb\u5df4\u7ed3\u6062\u590d\u6b63\u5e38\uff0c\u8fd9\u662f\u4e00\u4e2a\u975e\u5e38\u68d2\u7684\u3001\u610f\u60f3\u4e0d\u5230\u7684\u7ed3\u679c\u3002\u201dPharmAust\u7684\u9996\u5e2d\u79d1\u5b66\u5b98Richard Mollard\u535a\u58eb\u8bf4:\u201cMPL\u8840\u6db2\u6c34\u5e73\u8f83\u4f4e\u4e0e\u9884\u540e\u8f83\u597d\u4e4b\u95f4\u7684\u76f8\u5173\u6027\u4e5f\u662f\u4e00\u4e2a\u975e\u5e38\u79ef\u6781\u7684\u8d8b\u52bf\uff0c\u4e3a\u672a\u6765\u7684\u7b2c\u4e09\u9636\u6bb5\u8bd5\u9a8c\u63d0\u4f9b\u4e86\u66f4\u597d\u7684\u7ed3\u679c\u7684\u7075\u6d3b\u6027\u3002\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002 \u8be5\u8bd5\u9a8c\u76ee\u524d\u88ab\u6401\u7f6e\uff0c\u7b49\u5f85\u5f00\u53d1\u5408\u4f5c\u4f19\u4f34Elanco US\u7684\u4e2d\u671f\u62a5\u544a\uff0c\u6b64\u524d\u66fe\u6709\u72d7\u5728\u9ad8\u5242\u91cf\u6c34\u5e73\u4e0b\u51fa\u73b0\u809d\u9176\u5347\u9ad8\u548c\u98df\u6b32\u4e0d\u632f\u7684\u60c5\u51b5\u3002 \u5728\u5411\u5e02\u573a\u53d1\u5e03\u7684\u4e00\u4efd\u58f0\u660e\u4e2d\uff0c\u8be5\u516c\u53f8\u8868\u793a\uff0c\u5176\u6700\u65b0\u7684\u8bd5\u9a8c\u63d0\u4f9b\u4e86\u4e00\u4e2a\u201c\u6709\u610f\u4e49\u7684\u8d8b\u52bf\u201d\uff0c\u4e0e2017\u5e74\u7684\u6db2\u6001\u7248monepantel\u8bd5\u9a8c\u76f8\u6bd4\uff0c\u6548\u679c\u8fd8\u4e0d\u9519\u3002 \u6700\u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u8be5\u516c\u53f8\u5ba3\u5e03\u8be5\u8bd5\u9a8c\u5df2\u7ecf\u8fbe\u5230\u4e86\u6240\u6709\u7684\u4e3b\u8981\u76ee\u6807\uff0c\u5305\u62ec\u786e\u5b9amonepantel\u7247\u5242\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\uff0c\u8bc4\u4f30\u65b0\u5f00\u53d1\u7684monepantel\u7247\u5242\u5728\u60a3\u6709\u764c\u75c7\u7684\u72d7\u8eab\u4e0a\u7684\u836f\u7269\u4f20\u9012\u80fd\u529b\uff0c\u4ea7\u751f\u8db3\u591f\u7684\u6570\u636e\u4ee5\u4fbf\u4e0eElanco US\u8fdb\u4e00\u6b65\u8ba8\u8bba\uff0c\u53ef\u80fd\u6700\u91cd\u8981\u7684\u662f\u8db3\u591f\u7684\u6570\u636e\u8fdb\u5165\u7b2c\u4e09\u9636\u6bb5\u7684\u8bd5\u9a8c \u603b\u5171\u67096\u53ea\u72d7\u63a5\u53d7\u4e86monepantel\u6cbb\u7597\uff0c\u8fd9\u662f\u5728\u5bb6\u91cc\u8fdb\u884c\u768428\u5929\u6cbb\u7597\u8ba1\u5212\u7684\u4e00\u90e8\u5206\u3002 \u5728\u5b8c\u6210\u8bc4\u4f30\u7684\u72d7\u4e2d\uff0c\u4e00\u53ea\u72d7\u5b9e\u73b0\u4e86\u90e8\u5206\u53cd\u5e94\uff0c\u603b\u80bf\u7624\u8d1f\u62c5\u51cf\u5c11\u4e8660%\u4ee5\u4e0a\uff0c\u4e00\u4e2a\u6dcb\u5df4\u7ed3\u80bf\u7624\u5b8c\u5168\u6d88\u9000\u3002\u540c\u65f6\uff0c\u5728\u8bd5\u9a8c\u7ed3\u675f\u65f6\uff0c4\u53ea\u72d7\u75c5\u60c5\u7a33\u5b9a\uff0c1\u53ea\u72d7\u75c5\u60c5\u8fdb\u5c55\u3002 \u9664\u4e86\u4eca\u5929\u516c\u5e03\u7684\u7ed3\u679c\uff0cPharmAust\u8bf4\uff0c\u4ece\u8bd5\u9a8c\u671f\u95f4\u8bb0\u5f55\u7684\u8840\u6d46monepantel\u6c34\u5e73\u6765\u770b\uff0c\u6240\u6709\u72d7\u7684\u8840\u6d46monepantel\u6c34\u5e73\u90fd\u6bd42014\/2015\u5e74\u5728\u963f\u5fb7\u83b1\u5fb7\u7687\u5bb6\u533b\u9662\u8fdb\u884c\u7684\u4eba\u4f53\u8bd5\u9a8c\u8bb0\u5f55\u7684\u6c34\u5e73\u9ad850\u500d\u3002 \u201c\u5728\u8840\u6d46\u6c34\u5e73\u4e0a\u89c2\u5bdf\u5230\u4e00\u4e9b\u53d8\u5316\uff0c\u51fa\u4e4e\u610f\u6599\u7684\u662f\uff0c\u5728\u8f83\u4f4e\u7684\u8840\u6db2\u6c34\u5e73\u7684\u83ab\u5c3c\u73ed\u7279\u6709\u66f4\u597d\u7684\u7ed3\u679c\u3002\u201d\u8fd9\u4e00\u89c2\u5bdf\u7ed3\u679c\u53ef\u80fd\u4e0emTOR\u6291\u5236\u5242\u7684\u4f5c\u7528\u673a\u5236\u76f8\u4e00\u81f4\uff0c\u6709\u52a9\u4e8e\u51cf\u5c11\u548c\u4f18\u5316\u672a\u6765monepantel\u7247\u7684\u5242\u91cf\uff0c\u201d\u8be5\u516c\u53f8\u8bf4\u3002 \u503c\u5f97\u6ce8\u610f\u7684\u662f\uff0c\u8bd5\u9a8c\u7ed3\u679c\u663e\u793a\u4e0e\u5242\u91cf\u6709\u5173\u7684\u610f\u5916\u7ed3\u679c\u3002 \u636ePharmAust\u8bf4\uff0c\u7531\u4e8e\u9ad8\u5242\u91cf\u7684\u4f7f\u7528\uff0c\u4e00\u4e9b\u5ba0\u7269\u72d7\u51fa\u73b0\u98df\u6b32\u4e0d\u632f\u548c\u4f53\u91cd\u4e0b\u964d\u3002 \u56e0\u6b64\uff0c\u5ba0\u7269\u4e3b\u4eba\u62a5\u544a\u8bf4\u7ed9\u5ba0\u7269\u670d\u7528\u7247\u5242\u6709\u56f0\u96be\uff0c\u8fd9\u610f\u5473\u7740\u5728\u672a\u6765\u7684\u8bd5\u9a8c\u4e2d\u51cf\u5c11\u76ee\u6807\u5242\u91cf\u53ef\u80fd\u4f1a\u5728\u7597\u6548\u3001\u5b89\u5168\u6027\u548c\u7ed9\u5ba0\u7269\u7528\u836f\u65b9\u9762\u4ea7\u751f\u66f4\u597d\u7684\u7ed3\u679c\u3002 \u62bc\u6ce8monepantel PharmAust\u7684\u4e3b\u8981\u5019\u9009\u836f\u7269monepantel\u662fmTOR\u9014\u5f84\u7684\u6291\u5236\u5242\uff0cmTOR\u9014\u5f84\u88ab\u8ba4\u4e3a\u662f\u764c\u75c7\u7684\u5173\u952e\u9a71\u52a8\u56e0\u7d20\u3002 Monepantel\u5df2\u7ecf\u5728\u4eba\u7c7b\u548c\u72d7\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u8fdb\u884c\u4e86\u8bc4\u4f30\uff0c\u8010\u53d7\u6027\u826f\u597d\uff0c\u5e76\u4ea7\u751f\u4e86\u5173\u952e\u9884\u540e\u751f\u7269\u6807\u5fd7\u7269\u7684\u663e\u8457\u964d\u4f4e\u3002 \u6765\u81ea\u58a8\u5c14\u672c\u5927\u5b66\u548cU-Vet Werribee\u52a8\u7269\u533b\u9662\u7684Claire Cannon\u535a\u58eb\u8bf4:\u201cmonepantel\u4f3c\u4e4e\u5728\u60a3\u6709\u6dcb\u5df4\u7624\u7684\u72d7\u8eab\u4e0a\u663e\u793a\u51fa\u4e86\u6297\u764c\u6d3b\u6027\uff0c\u6211\u8ba4\u4e3a\uff0c\u73b0\u5728\u6709\u5fc5\u8981\u5bf9\u4f4e\u5242\u91cfmonepantel\u7684\u6709\u6548\u6027\u548c\u5b89\u5168\u6027\u8fdb\u884c\u4e09\u671f\u5bf9\u7167\u8bd5\u9a8c\u3002\u201d \u5979\u8bf4:\u201c\u7b2c\u4e8c\u9636\u6bb5\u8bd5\u9a8c\u7684\u7ed3\u679c\u8868\u660e\uff0cmonepantel\u53ef\u80fd\u4e0e\u6807\u51c6\u62a4\u7406\u6dcb\u5df4\u7624\u6cbb\u7597\u76f8\u7ed3\u5408\uff0c\u53ef\u80fd\u4ee3\u8868\u4e86\u6cbb\u7597\u8fd9\u79cd\u75be\u75c5\u7684\u72d7\u7684\u672a\u6765\u524d\u666f\u3002\u201d \u6839\u636ePharmAust\u7684\u8bf4\u6cd5\uff0c\u5b83\u73b0\u5728\u5904\u4e8e\u201c\u72ec\u7279\u7684\u5730\u4f4d\u201d\uff0c\u5728\u63a8\u8fdb\u836f\u7269\u7684\u7b2c\u4e8c\u9636\u6bb5\u4e34\u5e8a\u8bd5\u9a8c\u7684\u540c\u65f6\uff0c\u5c06monepantel\u7528\u4e8e\u6cbb\u7597\u4eba\u7c7b\u548c\u517d\u533b\u764c\u75c7\u7684\u5546\u4e1a\u5316\u3002 \u201c\u5728\u4e00\u53ea\u72d7\u8eab\u4e0a\uff0c\u670d\u7528monepantel\u7247\u53ef\u4ee5\u51cf\u5c1160%\u7684\u80bf\u7624\u8d1f\u62c5\uff0c\u8ba9\u4e00\u4e2a\u6dcb\u5df4\u7ed3\u6062\u590d\u6b63\u5e38\uff0c\u8fd9\u662f\u4e00\u4e2a\u975e\u5e38\u68d2\u7684\u3001\u610f\u60f3\u4e0d\u5230\u7684\u7ed3\u679c\u3002\u201dPharmAust\u7684\u9996\u5e2d\u79d1\u5b66\u5b98Richard Mollard\u535a\u58eb\u8bf4:\u201cMPL\u8840\u6db2\u6c34\u5e73\u8f83\u4f4e\u4e0e\u9884\u540e\u8f83\u597d\u4e4b\u95f4\u7684\u76f8\u5173\u6027\u4e5f\u662f\u4e00\u4e2a\u975e\u5e38\u79ef\u6781\u7684\u8d8b\u52bf\uff0c\u4e3a\u672a\u6765\u7684\u7b2c\u4e09\u9636\u6bb5\u8bd5\u9a8c\u63d0\u4f9b\u4e86\u66f4\u597d\u7684\u7ed3\u679c\u7684\u7075\u6d3b\u6027\u3002\u201d<\/p>\n","protected":false},"author":5,"featured_media":745,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[241],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c<\/title>\n<meta name=\"description\" content=\"\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta property=\"og:description\" content=\"\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-12T01:21:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/PharmAust-ASX-PAA-Monepantel-trial-anti-cancer-treat-anive-B-cell-lymphoma-MPL-tablet-pet-dog.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c\" \/>\n<meta name=\"twitter:description\" content=\"\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/PharmAust-ASX-PAA-Monepantel-trial-anti-cancer-treat-anive-B-cell-lymphoma-MPL-tablet-pet-dog.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/\",\"name\":\"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-05-12T01:21:22+00:00\",\"dateModified\":\"2023-08-29T18:02:05+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c","description":"\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c","og_description":"\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/","og_site_name":"smallcapsCN","article_published_time":"2020-05-12T01:21:22+00:00","article_modified_time":"2023-08-29T18:02:05+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/PharmAust-ASX-PAA-Monepantel-trial-anti-cancer-treat-anive-B-cell-lymphoma-MPL-tablet-pet-dog.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c","twitter_description":"\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/05\/PharmAust-ASX-PAA-Monepantel-trial-anti-cancer-treat-anive-B-cell-lymphoma-MPL-tablet-pet-dog.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/","url":"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/","name":"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-05-12T01:21:22+00:00","dateModified":"2023-08-29T18:02:05+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u80bf\u7624\u516c\u53f8PharmAust (ASX: PAA)\u4eca\u5929\u65e9\u4e0a\u4ece\u8dcc\u505c\u4e2d\u8d70\u51fa\u6765 \uff0c\u5ba3\u5e03\u5176monepantel\u72ac\u8bd5\u9a8c\u53d6\u5f97\u4e86\u201c\u6210\u529f\u7684\u7ed3\u679c\u201d\uff0c\u4e09\u671f\u8bd5\u9a8c\u5df2\u7ecf\u5728\u8fdb\u884c\u4e2d\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-progress-towards-next-clinical-trial-monepantel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"PharmAust\u6b63\u5728\u8fdb\u884cmonepantel\u7684\u4e0b\u4e00\u6b21\u4e34\u5e8a\u8bd5\u9a8c"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/744"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=744"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/744\/revisions"}],"predecessor-version":[{"id":7825,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/744\/revisions\/7825"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/745"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}